Chairman Rick Scott and Ranking Member Kirsten Gillibrand discussed their bipartisan CLEAR LABELS Act in a joint interview aired on WBMA, according to a Mar. 23 announcement. The proposed legislation would require country-of-origin labeling for prescription medicines and their ingredients sold in the United States.
The issue is significant because many prescription drugs and their components are manufactured overseas, particularly in China and India, while current federal labeling rules do not require disclosure of this information to patients or healthcare providers. The senators say the bill aims to increase transparency within the pharmaceutical supply chain so that Americans can make more informed decisions about their medications.
According to the announcement, "The CLEAR LABELS Act will bring greater transparency to the pharmaceutical supply chain, helping patients, pharmacists, and other purchasers make more informed decisions about the medications they rely on while supporting American jobs, strengthening domestic pharmaceutical manufacturing, and rebuilding a secure and reliable U.S. supply chain so families can have confidence that their medicines are safe, properly regulated, and clearly labeled."
Rick Scott serves as chair and Kirsten Gillibrand as ranking member of the Senate Aging Committee according to the official website. The committee focuses on examining issues affecting older Americans such as Social Security, Medicare, long-term care, retirement security; it also conducts hearings and issues reports according to its official website.
The Senate Aging Committee provides resources aimed at protecting older Americans from fraud through tools like a fraud hotline according to its official website. It maintains offices in both the Dirksen Senate Office Building (majority) and Hart Senate Office Building (minority) according to its official website.
The committee's oversight covers all Americans involved in aging-related federal programs nationwide according to its official website, including regular hearings focused on Medicare, Social Security, elder abuse prevention policy recommendations according to its official website.
Looking ahead, further developments regarding the CLEAR LABELS Act will be monitored by both senators as part of ongoing efforts by the committee.
